Quantitative proteomic analysis identifies new effectors of FOXM1 involved in breast cancer cell migration

Area of Science:

• Oncology
• Molecular Biology
• Proteomics

Background:

• The Forkhead Box M1 (FOXM1) transcription factor is crucial in human carcinomas, but its precise mechanisms are not fully understood.
• Understanding FOXM1's downstream targets is key to elucidating its role in tumorigenesis and metastasis.

Purpose of the Study:

• To identify novel downstream targets of FOXM1 in breast cancer using a quantitative proteomic approach.
• To investigate the functional significance of identified FOXM1 targets in breast cancer cell migration.

Main Methods:

• Quantitative proteomic analysis using label-free quantitation to compare FOXM1 knockdown and control breast cancer cells (MDA-MB-231).
• Western blot analysis to validate the expression levels of candidate proteins.
• Functional assays to assess the impact of target protein knockdown on cell migration.

Main Results:

• Over 4000 proteins were identified, with 318 significantly altered upon FOXM1 knockdown.
• ACSL4, CGGBP1, and PGRMC2 were identified as significantly downregulated proteins.
• Knockdown of ACSL4, CGGBP1, and PGRMC2 reduced MDA-MB-231 cell migration, mirroring FOXM1 knockdown effects.

Conclusions:

• Proteomic screening successfully identified potential new downstream targets of FOXM1 in breast cancer.
• The identified proteins ACSL4, CGGBP1, and PGRMC2 may mediate FOXM1's role in breast cancer cell migration.
• These findings suggest potential novel therapeutic targets for breast cancer treatment.